Literature DB >> 23645683

Proteolytic processing regulates placental growth factor activities.

Daniel C Hoffmann1, Sebastian Willenborg, Manuel Koch, Daniela Zwolanek, Stefan Müller, Ann-Kathrin A Becker, Stephanie Metzger, Martin Ehrbar, Peter Kurschat, Martin Hellmich, Jeffrey A Hubbell, Sabine A Eming.   

Abstract

Placental growth factor (PlGF) is a critical mediator of blood vessel formation, yet mechanisms of its action and regulation are incompletely understood. Here we demonstrate that proteolytic processing regulates the biological activity of PlGF. Specifically, we show that plasmin processing of PlGF-2 yields a protease-resistant core fragment comprising the vascular endothelial growth factor receptor-1 binding site but lacking the carboxyl-terminal domain encoding the heparin-binding domain and an 8-amino acid peptide encoded by exon 7. We have identified plasmin cleavage sites, generated a truncated PlGF118 isoform mimicking plasmin-processed PlGF, and explored its biological function in comparison with that of PlGF-1 and -2. The angiogenic responses induced by the diverse PlGF forms were distinct. Whereas PlGF-2 increased endothelial cell chemotaxis, vascular sprouting, and granulation tissue formation upon skin injury, these activities were abrogated following plasmin digestion. Investigation of PlGF/Neuropilin-1 binding and function suggests a critical role for heparin-binding domain/Neuropilin-1 interaction and its regulation by plasmin processing. Collectively, here we provide new mechanistic insights into the regulation of PlGF-2/Neuropilin-1-mediated tissue vascularization and growth.

Entities:  

Keywords:  Angiogenesis; Mechanism of Growth Factor Regulation; PlGF; Plasmin; Protease; Vascular Biology; Vascular Endothelial Growth Factor (VEGF)

Mesh:

Substances:

Year:  2013        PMID: 23645683      PMCID: PMC3689943          DOI: 10.1074/jbc.M113.451831

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis.

Authors:  Christiana Ruhrberg; Holger Gerhardt; Matthew Golding; Rose Watson; Sofia Ioannidou; Hajime Fujisawa; Christer Betsholtz; David T Shima
Journal:  Genes Dev       Date:  2002-10-15       Impact factor: 11.361

Review 2.  Gene transfer as a tool to induce therapeutic vascular growth.

Authors:  Seppo Ylä-Herttuala; Kari Alitalo
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

3.  Structural basis for selective vascular endothelial growth factor-A (VEGF-A) binding to neuropilin-1.

Authors:  Matthew W Parker; Ping Xu; Xiaobo Li; Craig W Vander Kooi
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

4.  Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain.

Authors:  Roni Mamluk; Ze'ev Gechtman; Matthew E Kutcher; Nijole Gasiunas; John Gallagher; Michael Klagsbrun
Journal:  J Biol Chem       Date:  2002-05-01       Impact factor: 5.157

5.  Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells.

Authors:  R Abu-Ghazaleh; J Kabir; H Jia; M Lobo; I Zachary
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

6.  Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds.

Authors:  G Lauer; S Sollberg; M Cole; I Flamme; J Stürzebecher; K Mann; T Krieg; S A Eming
Journal:  J Invest Dermatol       Date:  2000-07       Impact factor: 8.551

7.  Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment.

Authors:  Koichi Hattori; Beate Heissig; Yan Wu; Sergio Dias; Rafael Tejada; Barbara Ferris; Daniel J Hicklin; Zhenping Zhu; Peter Bohlen; Larry Witte; Jan Hendrikx; Neil R Hackett; Ronald G Crystal; Malcolm A S Moore; Zena Werb; David Lyden; Shahin Rafii
Journal:  Nat Med       Date:  2002-07-01       Impact factor: 53.440

8.  Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

Authors:  Aernout Luttun; Marc Tjwa; Lieve Moons; Yan Wu; Anne Angelillo-Scherrer; Fang Liao; Janice A Nagy; Andrea Hooper; Josef Priller; Bert De Klerck; Veerle Compernolle; Evis Daci; Peter Bohlen; Mieke Dewerchin; Jean-Marc Herbert; Roy Fava; Patrick Matthys; Geert Carmeliet; Désiré Collen; Harold F Dvorak; Daniel J Hicklin; Peter Carmeliet
Journal:  Nat Med       Date:  2002-07-01       Impact factor: 53.440

9.  A critical role of placental growth factor in the induction of inflammation and edema formation.

Authors:  Hajimu Oura; Jennifer Bertoncini; Paula Velasco; Lawrence F Brown; Peter Carmeliet; Michael Detmar
Journal:  Blood       Date:  2002-09-05       Impact factor: 22.113

10.  VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia.

Authors:  Holger Gerhardt; Matthew Golding; Marcus Fruttiger; Christiana Ruhrberg; Andrea Lundkvist; Alexandra Abramsson; Michael Jeltsch; Christopher Mitchell; Kari Alitalo; David Shima; Christer Betsholtz
Journal:  J Cell Biol       Date:  2003-06-16       Impact factor: 10.539

View more
  5 in total

1.  Myeloid Cell-Restricted Insulin/IGF-1 Receptor Deficiency Protects against Skin Inflammation.

Authors:  Jana Knuever; Sebastian Willenborg; Xiaolei Ding; Mehmet D Akyüz; Linda Partridge; Carien M Niessen; Jens C Brüning; Sabine A Eming
Journal:  J Immunol       Date:  2015-10-30       Impact factor: 5.422

2.  Sustained Placental Growth Factor-2 Treatment Does Not Aggravate Advanced Atherosclerosis in Ischemic Cardiomyopathy.

Authors:  Ming Wu; Peter Pokreisz; Melissa Swinnen; Ellen Caluwe; Hilde Gillijns; Nina Vanden Driessche; Andrea Casazza; Erik Verbeken; Desire Collen; Stefan Janssens
Journal:  J Cardiovasc Transl Res       Date:  2017-04-10       Impact factor: 4.132

Review 3.  Wound repair and regeneration: mechanisms, signaling, and translation.

Authors:  Sabine A Eming; Paul Martin; Marjana Tomic-Canic
Journal:  Sci Transl Med       Date:  2014-12-03       Impact factor: 17.956

4.  A computational analysis of in vivo VEGFR activation by multiple co-expressed ligands.

Authors:  Lindsay E Clegg; Feilim Mac Gabhann
Journal:  PLoS Comput Biol       Date:  2017-03-20       Impact factor: 4.475

Review 5.  Wound Repair and Extremely Low Frequency-Electromagnetic Field: Insight from In Vitro Study and Potential Clinical Application.

Authors:  Giulio Gualdi; Erica Costantini; Marcella Reale; Paolo Amerio
Journal:  Int J Mol Sci       Date:  2021-05-10       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.